A practical reference on anti-doping testing: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-19 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small molecule | Studied as a REV-ERB agonist |
| Molecular formula | C20H24ClN3O4S | Reported for the neutral compound |
| Appearance | Off-white to pale yellow solid | Typical research-grade material |
| Solubility | Sparingly soluble in water | Soluble in solvents such as DMSO |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal alias |
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
paracellular transport The transfer of substances across an epithelium by passing through the extracellular space between cells, in contrast to transcellular transport, where substances travel through cells by crossing the intracellular cytoplasm.
He beat Andrey Rublev for the 17th title of his career and the fourth of the season, in 59 minutes, the shortest match in the tournament history. At the US Open, Zverev sought to claim his first major title following his run to the final the previous year. He reached the semifinals following wins over Jack Sock and Lloyd Harris. There, he lost to Novak Djokovic in five sets despite taking the first set, ending his career-high 16-match win streak stretching back to the Olympics. Zverev was seeded 3rd at the 2021 BNP Paribas Open, where he reached the quarterfinals. On the way, he defeated Jenson Brooksby, Andy Murray and Gaël Monfils. He lost to Taylor Fritz, despite having two match points. At the Erste Bank Open in Vienna, seeded second, he defeated Filip Krajinović and Alex de Minaur to reach the quarterfinals. The victory over De Minaur gave Zverev his 300th ATP tour match win. He then beat Félix Auger-Aliassime and Carlos Alcaraz to reach the final where he won his fifth title of the year and 18th overall, defeating Frances Tiafoe in straight sets. Zverev was the fourth seed at the 2021 Rolex Paris Masters. He received a bye into the second round, where he defeated Dušan Lajović. He defeated next sixteenth seed Grigor Dimitrov in the third round and sixth seed Casper Ruud in the quarterfinals. He lost in the semifinals to second seed Daniil Medvedev in straight sets. As a result of this run he equaled his singles career-high ranking of World No. 3 on 8 November 2021. For a fifth successive season, Zverev qualified for the 2021 ATP Finals in Turin, as the third seed.
The Don Cossack Host (Russian: Всевеликое Войско Донское, Vsevelikoye Voysko Donskoye) was either an independent or an autonomous democratic republic, located in present-day Southern Russia. It existed from the end of the 16th century until the early 20th century. There are two main theories of the origin of the Don Cossacks. Most respected historians support the migration theory, according to which they were Slavic colonists. The various autochthonous theories popular among the Cossacks themselves do not find confirmation in genetic studies. The gene pool comprises mainly the East Slavic component, with a significant Ukrainian contribution. There is no influence of the peoples of the Caucasus; and the steppe populations, represented by the Nogais, have only limited impact. The majority of Don Cossacks are either Eastern Orthodox or Christian Old Believers (старообрядцы). Prior to the Russian Civil War, there were numerous religious minorities, including Muslims, Subbotniks, and Jews.
Sources: en.wikipedia.org
In order to establish itself as an American empire, Spain had to fight against the relatively powerful civilizations of the New World. The Spanish conquest of the indigenous peoples in the Americas included using the Natives as forced labour. The Spanish colonies were the first Europeans to use African slaves in the New World on islands such as Cuba and Hispaniola. It was argued by some contemporary writers to be intrinsically immoral. Bartolomé de las Casas, a 16th-century Dominican friar and Spanish historian, participated in campaigns in Cuba (at Bayamo and Camagüey) and was present at the massacre of Hatuey; his observation of that massacre led him to fight for a social movement away from the use of natives as slaves. Also, the alarming decline in the native population had spurred the first royal laws protecting the native population. The first African slaves arrived in Hispaniola in 1501. This era saw a growth in race-based slavery. England played a prominent role in the Atlantic slave trade. The "slave triangle" was pioneered by Francis Drake and his associates, though English slave-trading would not take off until the mid-17th century. Many whites who arrived in North America during the 17th and 18th centuries came under contract as indentured servants. The transformation from indentured servitude to slavery was a gradual process in Virginia.
Once all the eggs are secured in the nest, the pair will spawn again. If more than one female is present in the breeding tank, the male may spawn with all of them. The spawning sessions will continue for two to four hours, and produce between 300 and 800 eggs. Dwarf gouramis have a fecundity of about 600 eggs.[1] Upon completion, the male will place a fine layer of bubbles beneath the eggs, assuring that they remain in the bubble nest. The male will protect the eggs and fry. In 12 to 24 hours the fry will hatch, and continue developing within the protection of the bubble nest. After three days they are sufficiently developed to be free swimming and leave the nest. When the fry are two to three days old the male should also be removed or he may consume the young. After spawning the female should be moved to a different tank. The male will now take sole responsibility for the eggs, aggressively defending the nest and surrounding territory. When first hatched, the tiny fry should be fed infusoria, and later, brine shrimp and finely ground flakes. Freeze-dried tablets may also be fed to older fry.
On June 23, 2021, the NPR station CapRadio reported that Newsom and Cal Fire had falsely claimed in January 2020 that 90,000 acres (36,000 ha) of land at risk for wildfires had been treated with fuel breaks and prescribed burns; the actual treated area was 11,399 acres (4,613 ha), an overstatement of 690%. According to CapRadio, the fuel breaks of the 35 "priority projects" Newsom had touted, which were meant to ensure the quick evacuation of residents while preventing traffic jams and a repeat of events in the 2018 fire that destroyed the town of Paradise, where at least eight evacuees burned to death in their vehicles, were struggling to mitigate fire spread in almost every instance while failing to prevent evacuation traffic jams. The same day CapRadio revealed the oversight, leaked emails showed that Newsom's handpicked Cal Fire chief had ordered the removal of the original statement. In another report in April 2022, CapRadio found a program, hailed in 2020 by the Newsom administration to fast-track environmental reviews on high-priority fire prevention projects, had failed to make progress. KXTV released a series of reports chronicling PG&E's liabilities after committing 91 felonies in the Santa Rosa and Paradise fires. Newsom was accused of accepting campaign donations from PG&E in order to change the CPUC's ruling on PG&E's safety license. The rating change allowed PG&E to avoid billions of dollars in extra fees.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.
No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.
Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.